{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:52:20Z","timestamp":1790268740985,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_013\/0001775"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_013\/0001775"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["UNCE 204064"],"award-info":[{"award-number":["UNCE 204064"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["SVV260521"],"award-info":[{"award-number":["SVV260521"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_013\/0001775"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_013\/0001775"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014809","name":"Technology Agency of the Czech Republic","doi-asserted-by":"publisher","award":["FW02020128"],"award-info":[{"award-number":["FW02020128"]}],"id":[{"id":"10.13039\/100014809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014809","name":"Technology Agency of the Czech Republic","doi-asserted-by":"publisher","award":["TN01000013"],"award-info":[{"award-number":["TN01000013"]}],"id":[{"id":"10.13039\/100014809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NU22-08-00160"],"award-info":[{"award-number":["NU22-08-00160"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NU21-08-00407"],"award-info":[{"award-number":["NU21-08-00407"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008667","name":"National Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004578","name":"Ministry of Industry and Trade of the Czech Republic","doi-asserted-by":"publisher","award":["FV40120"],"award-info":[{"award-number":["FV40120"]}],"id":[{"id":"10.13039\/501100004578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["LX22NPO5102"],"award-info":[{"award-number":["LX22NPO5102"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["LX22NPO5107"],"award-info":[{"award-number":["LX22NPO5107"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.biopha.2022.113736","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T07:36:12Z","timestamp":1663918572000},"page":"113736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells"],"prefix":"10.1016","volume":"155","author":[{"given":"Tereza","family":"Brogy\u00e1nyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kapl\u00e1nek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"Kej\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017eena","family":"Hosnedlov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Antonyov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Abramenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Vesel\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Mart\u00e1sek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vokurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Des R.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Jakubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2022.113736_bib1","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1039\/C7MT00116A","article-title":"The elemental role of iron in DNA synthesis and repair","volume":"9","author":"Puig","year":"2017","journal-title":"Metallomics"},{"issue":"1","key":"10.1016\/j.biopha.2022.113736_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.abb.2012.09.002","article-title":"NADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family","volume":"528","author":"Iyanagi","year":"2012","journal-title":"Arch. Biochem Biophys."},{"issue":"4","key":"10.1016\/j.biopha.2022.113736_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00775-018-1548-6","article-title":"Iron-sulfur clusters: from metals through mitochondria biogenesis to disease","volume":"23","author":"Cardenas-Rodriguez","year":"2018","journal-title":"J. Biol. Inorg. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2022.113736_bib4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3390\/biom5020808","article-title":"Oxidative stress and the homeodynamics of iron metabolism","volume":"5","author":"Bresgen","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2022.113736_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2018.07.009","article-title":"A promising new approach to cancer therapy: targeting iron metabolism in cancer stem cells","volume":"53","author":"El Hout","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113736_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/inorganics6040126","article-title":"Iron and copper intracellular chelation as an anticancer drug strategy","volume":"6","author":"Gaur","year":"2018","journal-title":"Inorganics"},{"issue":"17","key":"10.1016\/j.biopha.2022.113736_bib7","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2174\/092986712800609706","article-title":"Iron chelators for the treatment of cancer","volume":"19","author":"Yu","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113736_bib8","unstructured":"Chuang, T.Y., et al., Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications, Annals of Hematology, 6."},{"issue":"40","key":"10.1016\/j.biopha.2022.113736_bib9","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2022.113736_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijms20020273","article-title":"Iron as a central player and promising target in cancer progression","volume":"20","author":"Jung","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113736_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/03630260500455367","article-title":"PCTH: a novel orally active chelator for the treatment of iron overload disease","volume":"30","author":"Lovejoy","year":"2006","journal-title":"Hemoglobin"},{"key":"10.1016\/j.biopha.2022.113736_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/srep38343","article-title":"Iron chelators target both proliferating and quiescent cancer cells","volume":"6","author":"Fryknas","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2022.113736_bib13","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/12081910","article-title":"Biological activities of hydrazone derivatives","volume":"12","author":"Rollas","year":"2007","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.biopha.2022.113736_bib14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.bmc.2015.01.029","article-title":"Synthesis and biological activity evaluation of hydrazone derivatives based on a Troger's base skeleton","volume":"23","author":"Kaplanek","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113736_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bioorg.2015.03.003","article-title":"Caffeine-hydrazones as anticancer agents with pronounced selectivity toward T-lymphoblastic leukaemia cells","volume":"60","author":"Kaplanek","year":"2015","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2022.113736_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00044-016-1756-y","article-title":"Hydrazide-hydrazones as potential antimicrobial agents: overview of the literature since 2010","volume":"26","author":"Popiolek","year":"2017","journal-title":"Med Chem. Res."},{"issue":"5","key":"10.1016\/j.biopha.2022.113736_bib17","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.ejmech.2010.01.028","article-title":"Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide\/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity","volume":"45","author":"Pavan","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113736_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2018.02.084","article-title":"Metallomics for Alzheimer's disease treatment: use of new generation of chelators combining metal-cation binding and transport properties","volume":"150","author":"D'Acunto","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113736_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.02.034","article-title":"Hydrazones as novel epigenetic modulators: correlation between TET 1 protein inhibition activity and their iron(II) binding ability","volume":"88","author":"Jakubek","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2022.113736_bib20","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.18632\/oncotarget.6233","article-title":"Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy","volume":"7","author":"Wilfinger","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.113736_bib21","article-title":"Role of mtDNA disturbances in the pathogenesis of Alzheimer\u2019s and Parkinson\u2019s disease","volume":"91\u201392","author":"Antonyov\u00e1","year":"2020","journal-title":"DNA Repair"},{"key":"10.1016\/j.biopha.2022.113736_bib22","article-title":"Novel mitochondria-targeted drugs for cancer therapy","author":"Fialova","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113736_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fcell.2020.00413","article-title":"The role of mitochondrial dynamics and mitophagy in carcinogenesis, metastasis and therapy","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2022.113736_bib24","article-title":"Mitophagy in pancreatic cancer","volume":"11","author":"Xie","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113736_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41401-019-0260-6","article-title":"Somatic and germline mutations in the tumor suppressor gene PARK2 impair PINK1\/Parkin-mediated mitophagy in lung cancer cells","volume":"41","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.biopha.2022.113736_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/cells9010147","article-title":"IGF-1 signalling regulates mitochondria dynamics and turnover through a conserved GSK-3 beta-Nrf2-BNIP3 pathway","volume":"9","author":"Riis","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.113736_bib27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2019.05.020","article-title":"Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer","volume":"157","author":"Park","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2022.113736_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.gene.2020.144552","article-title":"Hypoxia-induced elevated NDRG1 mediates apoptosis through reprograming mitochondrial fission in HCC","volume":"741","author":"Guo","year":"2020","journal-title":"Gene"},{"issue":"9","key":"10.1016\/j.biopha.2022.113736_bib29","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood-2004-05-1866","article-title":"Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation","volume":"104","author":"Le","year":"2004","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.biopha.2022.113736_bib30","doi-asserted-by":"crossref","first-page":"9692","DOI":"10.1074\/jbc.M113.529511","article-title":"The metastasis suppressor, N-myc downstream-regulated gene 1 (NDRG1), inhibits stress-induced autophagy in cancer cells","volume":"289","author":"Sahni","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.113736_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114374","article-title":"The azulene scaffold from a medicinal chemist's perspective: physicochemical and in vitro parameters relevant for drug discovery","volume":"237","author":"Leino","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2022.113736_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3891\/acta.chem.scand.18-1085","article-title":"High-speed computers as supplement to graphical methods.3. twist matrix methods for minimizing error-square sum in problems with many unknown constants","volume":"18","author":"Sillen","year":"1964","journal-title":"Acta Chem. Scand."},{"issue":"1","key":"10.1016\/j.biopha.2022.113736_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10610278.2018.1523409","article-title":"Benzoisothiazole-1,1-dioxide-based synthetic receptor for zinc ion recognition in aqueous medium and its interaction with nucleic acids","volume":"31","author":"Jakubek","year":"2019","journal-title":"Supramol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2022.113736_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/10610278.2017.1414216","article-title":"Perimidine-based synthetic receptors for determination of copper(II) in water solution","volume":"30","author":"Jakubek","year":"2018","journal-title":"Supramol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2022.113736_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10610278.2016.1153095","article-title":"Water soluble chromone Schiff base derivatives as fluorescence receptor for aluminium(III)","volume":"29","author":"Jakubek","year":"2017","journal-title":"Supramol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2022.113736_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cbdd.13782","article-title":"Spectroscopic study of in situ-formed metallocomplexes of proton pump inhibitors in water","volume":"97","author":"Abramenko","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2022.113736_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105793","article-title":"Non-psychotropic cannabinoids as inhibitors of TET1 protein","volume":"124","author":"Antonyov\u00e1","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"48","key":"10.1016\/j.biopha.2022.113736_bib38","doi-asserted-by":"crossref","first-page":"17188","DOI":"10.1073\/pnas.1419554111","article-title":"Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent","volume":"111","author":"Alkasalias","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"30","key":"10.1016\/j.biopha.2022.113736_bib39","doi-asserted-by":"crossref","first-page":"29694","DOI":"10.18632\/oncotarget.5088","article-title":"Differential targeting of the cyclin-dependent kinase inhibitor, p21(CIP1\/WAF1), by chelators with anti-proliferative activity in a range of tumor cell-types","volume":"6","author":"Moussa","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2022.113736_bib40","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/00304949509458513","article-title":"Synthesis of 1,3-Dimethylazulene","volume":"27","author":"Irvine","year":"1995","journal-title":"Org. Prep. Proced. Int."},{"issue":"12","key":"10.1016\/j.biopha.2022.113736_bib41","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1080\/00397910802654658","article-title":"Microwave-Assisted synthesis and antifungal activity of 2,5-disubstituted-1,3,4-oxadiazoles containing azulene moiety","volume":"39","author":"Xu","year":"2009","journal-title":"Synth. Commun."},{"issue":"21","key":"10.1016\/j.biopha.2022.113736_bib42","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1080\/00397910802213752","article-title":"Polystyrene-supported iodobenzene diacetate (PSIBD)-mediated synthesis of 1,2-diacylbenzenes from 2-hydroxyaryl aldehyde\/ketone acylhydrazones","volume":"38","author":"Kumar","year":"2008","journal-title":"Synth. Commun."},{"key":"10.1016\/j.biopha.2022.113736_bib43","doi-asserted-by":"crossref","DOI":"10.1124\/mol.111.073627","article-title":"Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor, NDRG1: a new strategy for the treatment of pancreatic cancer","author":"Kovacevic","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113736_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.03.024","article-title":"Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues","volume":"170","author":"Siqueira","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.113736_bib45","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.14309\/00000434-201410002-00289","article-title":"The effect of deferoxamine on the proliferation of pancreatic cancer cell lines: 289","volume":"109","author":"Qin","year":"2014","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG"},{"issue":"10","key":"10.1016\/j.biopha.2022.113736_bib46","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1074\/jbc.M116.772699","article-title":"Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones","volume":"293","author":"Al-Akra","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2022.113736_bib47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12020-020-02228-1","article-title":"Increased autophagy\/mitophagy levels in primary tumours of patients with pancreatic neuroendocrine neoplasms","volume":"68","author":"Daskalakis","year":"2020","journal-title":"Endocrine"},{"issue":"12","key":"10.1016\/j.biopha.2022.113736_bib48","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/embor.2013.168","article-title":"Loss of iron triggers PINK1\/Parkin-independent mitophagy","volume":"14","author":"Allen","year":"2013","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.biopha.2022.113736_bib49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbrc.2016.10.088","article-title":"Mitophagy: link to cancer development and therapy","volume":"482","author":"Kulikov","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2022.113736_bib50","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/carcin\/bgl146","article-title":"The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer","volume":"27","author":"Kovacevic","year":"2006","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.biopha.2022.113736_bib51","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1248\/bpb.27.624","article-title":"N-myc downregulated gene 1 is a phosphorylated protein in mast cells","volume":"27","author":"Sugiki","year":"2004","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.biopha.2022.113736_bib52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","article-title":"The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113736_bib53","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/MCB.26.6.2373-2386.2006","article-title":"Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis","volume":"26","author":"O'Donnell","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"15","key":"10.1016\/j.biopha.2022.113736_bib54","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.7150\/thno.41792","article-title":"Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer","volume":"10","author":"Lu","year":"2020","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.biopha.2022.113736_bib55","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.18632\/oncotarget.2948","article-title":"Inhibition of HIF-1 alpha by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.113736_bib56","unstructured":"\u3008http:\/\/www.openmolecules.org\/propertyexplorer\/applet.html\u3009."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222011258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222011258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:21:38Z","timestamp":1781781698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222011258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":56,"alternative-id":["S0753332222011258"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113736","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113736"}}